Pathways' Pick of the Week: Canada’s Premarket Plans for ML-Enabled Devices
Market Pathways
Exploring the people, challenges, and opportunities impacting the global medtech regulatory and reimbursement community.
ARTICLE SUMMARY:
Health Canada has issued a draft guidance on premarket expectations for machine learning-enabled devices. Excerpted from Pathways’ Picks August 30: Canada Drafts Machine Learning Guide, Labs Speak Out, and More.
Health Canada posted a draft guidance August 30 outlining its expectations for?premarket submissions of machine learning-enabled devices.
The draft details how companies should go about demonstrating safety and effectiveness of such devices, and it address issues like bias, drift, training data, and transparency.
The document also offers the opportunity for predetermined change control plans (PCCPs) as mechanism for companies to get pre-authorization from Health Canada for planned software updates, aligning in many respects with FDA’s March draft guidance on PCCPs for AI/ML devices.
Comments on Health Canada’s document are due October 29.?
Continue reading Pathways’ Picks here.
Request to trial?MyStrategist.com?and?unlock 5-days of exclusive??subscriber-only access?to the medical device industry's most trusted strategic publications:?MedTech Strategist?&?Market Pathways.
Stay informed and get bonus content with our community newsletter by signing up?here.
Remain informed on medtech regulatory, reimbursement and policy, new podcast episodes and more with our strategic community newsletter. Subscribe here: https://bit.ly/42NcsHc